Collaborative agreement gives OGT access to Agilent's microarray platform, confirming OGT as an Agilent Certified Service Provider, and appointing Agilent as OEM supplier for OGT designed microarrays
OGT and Agilent, joint pioneers of the development of the Ink Jet In-situ synthesis (IJISS) and SurePrint platforms, will combine the experience and expertise of OGT in microarray services with Agilent's microarray platform to provide an end-to-end solution, giving the customer a flexible platform using high density, high sensitivity microarrays, tailored to application services.
Combining OGT's experience in custom microarray design and data analysis with Agilent's microarray tools including the Agilent 2100 Bioanalyser and GeneSpring software suite will enable OGT and Agilent to jointly develop a centre of microarray excellence targeting new emerging applications including aCGH, ChIP, methylation and microRNA.
The OEM supply of OGT designed microarrays (by Agilent) will assist OGT in the development of their products, in particular, the recently launched Chip2 prokaryotic ChIP on chip range and products in the development pipeline such as aCGH.
Mike Evans, chief executive at OGT said: "OGT and Agilent have always had a close collaborative relationship.
"This agreement is very exciting for OGT and Agilent as it gives our companies the opportunity to excel as a global centre of excellence".
Yvonne Linney, general manager for genomics at Agilent, said: "Agilent and OGT share a vision of energising the discovery process through freedom of experiment design, highly sensitive tools and reproducible results.
"This close collaboration is the logical extension of this vision to a wider segment of the research community."
